Preliminary research is promising however much more study is needed to determine the safety efficacy and best practices involved with stem cell therapy for relapsing remitting and progressive ms.
Stem cell replacement and ms.
Stem cells are found in both embryos and adults.
Over an average of three years ms progressed in 34 of 55 patients on medication meaning their disabilities worsened.
One trial of 24 people with rrms found that 69 who had stem cell therapy didn t have a relapse in ms symptoms or new brain lesions which are caused by ms 5 years after treatment.
The tisch multiple sclerosis research center of new york is currently recruiting for an fda approved stem cell trial but applicants must be part of international multiple sclerosis management.
Hsct hematopoietic stem cell transplantation attempts to reboot the immune system which is responsible for damaging the brain and spinal cord in ms.
In hsct for ms hematopoietic blood cell producing stem cells which are derived from a person s own scientifically referred to as autologous bone marrow or blood are collected and stored prior to depleting much of the.
Many types of stem cells are being explored for their potential benefits for treating multiple sclerosis.